Producing Transgenic Pigs for Xenotransplantation – Selection of Founder Animals and Establishment of Breeding Herds

Producing Transgenic Pigs for Xenotransplantation – Selection of Founder Animals and Establishment of Breeding Herds

Aus dem Department für Veterinärwissenschaften der Tierärztlichen Fakultät der Ludwig-Maximilians-Universität München Arbeit angefertigt unter der Leitung von Univ.-Prof. Dr. Eckhard Wolf (Re)producing transgenic pigs for xenotransplantation – selection of founder animals and establishment of breeding herds Inaugural Dissertation zur Erlangung der tiermedizinischen Doktorwürde der Tierärztlichen Fakultät der Ludwig-Maximilians-Universität München von Andrea Bähr aus München München 2011 Gedruckt mit der Genehmigung der Tierärztlichen Fakultät der Ludwig-Maximilians-Universität München Dekan: Univ.-Prof. Dr. Braun Berichterstatter: Univ.-Prof. Dr. Wolf Korreferent: Univ.-Prof. Dr. Zerbe Tag der Promotion 30. Juli 2011 Für den Puck TABLE OF CONTENTS 1 INTRODUCTION ......................................................................................1 2 REVIEW OF THE LITERATURE ..........................................................3 2.1 The pig as a model species in biomedical research ................................ 3 2.2 Established pig models .............................................................................. 4 2.2.1 Neurodegenerative diseases ........................................................................ 4 2.2.2 Cardiovascular diseases ............................................................................... 6 2.2.3 Diabetes mellitus ......................................................................................... 7 2.2.4 Cystic Fibrosis ............................................................................................. 9 2.3 Pigs as donor animals in the context of xenotransplantation .............. 11 2.3.1 Hyperacute xenograft rejection ................................................................. 12 2.3.2 Acute humoral xenograft rejection ............................................................ 14 2.3.3 Cell-mediated xenograft rejection ............................................................. 16 2.4 (Re)producing transgenic pigs ............................................................... 17 2.4.1 Pig breeds and pig breeding ...................................................................... 19 2.4.2 Inbreeding depression ............................................................................... 22 2.4.3 Inbreeding in pig livestock and experimental animals .............................. 24 2.5 Selection of breeding material – expression analysis ........................... 28 3 ANIMALS, MATERIALS AND METHODS ........................................33 3.1 Animals ..................................................................................................... 33 3.1.1 GalKO ....................................................................................................... 33 3.1.2 CD46 ......................................................................................................... 33 3.1.3 hTM ........................................................................................................... 34 3.1.4 HLA-E ....................................................................................................... 34 3.1.5 LEA29Y .................................................................................................... 35 3.2 Materials .................................................................................................. 36 3.2.1 Chemicals .................................................................................................. 36 3.2.2 Consumables ............................................................................................. 37 3.2.3 Devices ...................................................................................................... 38 3.2.4 Antibodies, drugs, enzymes, oligonucleotides, standards ......................... 39 I Table of contents 3.2.4.1 Antibodies ................................................................................................. 39 3.2.4.2 Drugs ......................................................................................................... 39 3.2.4.3 Enzymes .................................................................................................... 39 3.2.4.4 Oligonucleotides ........................................................................................ 40 3.2.4.5 Protein standards ....................................................................................... 42 3.2.5 Buffers, media, solutions ........................................................................... 42 3.2.6 Kits ............................................................................................................ 48 3.2.7 Others ........................................................................................................ 48 3.2.8 Software .................................................................................................... 48 3.3 Methods .................................................................................................... 49 3.3.1 Genomic analysis ...................................................................................... 49 3.3.1.1 Genotyping of founder animals and F1 generation ................................... 49 3.3.1.2 Duplex PCR ............................................................................................... 51 3.3.1.3 Agarose Gel Electrophoresis ..................................................................... 52 3.3.1.4 Southern Blot ............................................................................................. 52 3.3.1.5 Inverse Polymerase Chain Reaction (inverse PCR) .................................. 56 3.3.1.5.1 Genomic DNA isolation ............................................................................ 57 3.3.1.5.2 DNA fragmentation ................................................................................... 57 3.3.1.5.3 Circularisation of DNA fragments ............................................................ 58 3.3.1.5.4 Nested PCR ............................................................................................... 59 3.3.1.5.5 DNA Eluation ............................................................................................ 62 3.3.1.5.6 Ligation ..................................................................................................... 62 3.3.1.5.7 Heat Shock Transformation ...................................................................... 63 3.3.1.5.8 Plasmid preparation ................................................................................... 63 3.3.1.5.9 Restriction digest ....................................................................................... 64 3.3.1.5.10 PEG precipitation ...................................................................................... 64 3.3.1.5.11 Sequencing ................................................................................................ 65 3.3.1.5.12 EtOH precipitation .................................................................................... 66 3.3.2 Expression analysis ................................................................................... 66 3.3.2.1 Protein isolation ......................................................................................... 67 3.3.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) ..................................... 67 II Table of contents 3.3.2.3 Immunohistochemistry .............................................................................. 69 3.3.3 Calculation of inbreeding coefficient ........................................................ 70 3.3.4 Design of breeding schedules .................................................................... 71 4 RESULTS ..................................................................................................73 4.1 Identification of suitable breeding herds .............................................. 73 4.2 Selection of founder animals .................................................................. 74 4.3 Expression and functional analysis of novel transgenic lines .............. 75 4.3.1 hTM ........................................................................................................... 75 4.3.1.1 Clarification of hTM transgene integration site ........................................ 79 4.3.2 INS-LEA ................................................................................................... 83 4.3.3 CAG-LEA ................................................................................................. 88 4.4 Breeding schedules .................................................................................. 92 4.5 Breeding & analysis of intermediate (F1) generations ........................ 99 4.6 F2 generations and hTM incorporation into breeding herd ............. 108 4.7 Identification of transgene zygosity ..................................................... 109 4.7.1 GalKO duplex PCR ................................................................................. 109 4.7.2 hTM duplex PCR .................................................................................... 111 5 DISCUSSION .........................................................................................113 6 SUMMARY .............................................................................................125 7 ZUSAMMENFASSUNG .......................................................................129 8 INDEX OF FIGURES ............................................................................133

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    188 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us